ZyVersa to Showcase Breakthrough Kidney Disease Drug at JPM Healthcare Conference 2025
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
ZyVersa Therapeutics (NASDAQ: ZVSA) announces CEO Stephen C. Glover's attendance at JPM's 43rd Annual Healthcare...
Relatives of a Cuban woman who suffered from kidney problems reported her death due to a lack of medical care...
The landscape of kidney disease is ever-changing. Globally, changes in lifestyle have led to a steady increase in obesity and...
Dr. Stalin Dharmayan went right to work Nov. 1, his first day as surgical director of UPMC Hamot's kidney transplant...
ABSTRACTObjectives: In 2016, Dallas Nephrology Associates recognized that the economic, humanistic, and societal burden of end-stage kidney disease was unsustainable...
The extent by which potentially inappropriate medications or monitoring is given to people with CKD has not been sufficiently evaluated,...